American Well Corporation
AMWL | NYSE
$13.18
-$0.24 (-1.79%)
At close: Sep 22, 2026, 3:59 PM ET
$13.21
+$0.03 (+0.23%)
After-hours:
Sep 22, 2026, 6:10 PM ET
Company Profile
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care. It also provides specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members; Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Key Executives
| Name | Position |
|---|---|
| Ido Schoenberg | Chairman & Chief Executive Officer |
| Mark J. Hirschhorn | Executive Vice President, Chief Operating Officer & Chief Financial Officer |
| Anna Nesterova | Head of Legal & Deputy General Counsel |
| Cynthia Horner FAAFP | Chief Medical Officer & President of Amwell Medical Group |
| Dan Zamansky | Chief Product & Technology Officer |
| Michael Miller | Senior Vice President & Chief Sales Officer |
| Paul Francis McNeice | Vice President of Accounting |
| Phyllis I. Gotlib | President of Amwell International |
| Sue Dooley | Head of Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 03, 2026 | 4 | Filing |
| Sep 03, 2026 | 4 | Filing |
| Sep 03, 2026 | 4 | Filing |
| Aug 13, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 04, 2026 | 10-Q | Quarterly Report |
| Aug 04, 2026 | 8-K | Current Report |
| Jul 21, 2026 | 8-K | Current Report |
| Jul 14, 2026 | 8-K | Current Report |
| Jul 01, 2026 | 4 | Filing |
| Jul 01, 2026 | 4 | Filing |
American Well Corporation
| Country | United States |
| IPO Date | Sep 16, 2020 |
| Industry | Medical - Healthcare Information Services |
| Sector | Healthcare |
| Employees | 562 |
| CEO | Ido Schoenberg |
Contact Details
75 State Street Boston,
Massachusetts 02109 United States
Stock Details
| Ticker Symbol | AMWL |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001393584 |
| CUSIP Number | 03044L204 |
| ISIN Number | US03044L2043 |
| SIC Code | 7389 |
Add to Watchlist
Select watchlists to add or remove AMWL